141 related articles for article (PubMed ID: 20500508)
1. Validating bladder cancer xenograft bioluminescence with magnetic resonance imaging: the significance of hypoxia and necrosis.
Black PC; Shetty A; Brown GA; Esparza-Coss E; Metwalli AR; Agarwal PK; McConkey DJ; Hazle JD; Dinney CP
BJU Int; 2010 Dec; 106(11):1799-804. PubMed ID: 20500508
[TBL] [Abstract][Full Text] [Related]
2. A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging.
Hadaschik BA; Black PC; Sea JC; Metwalli AR; Fazli L; Dinney CP; Gleave ME; So AI
BJU Int; 2007 Dec; 100(6):1377-84. PubMed ID: 17850390
[TBL] [Abstract][Full Text] [Related]
3. Optimizing live-animal bioluminescence imaging prediction of tumor burden in human prostate cancer xenograft models in SCID-NSG mice.
Kim S; Zhang Y; Tang S; Qin C; Karelia D; Sharma A; Jiang C; Lu J
Prostate; 2019 Jun; 79(9):949-960. PubMed ID: 30958914
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect.
Szentirmai O; Baker CH; Lin N; Szucs S; Takahashi M; Kiryu S; Kung AL; Mulligan RC; Carter BS
Neurosurgery; 2006 Feb; 58(2):365-72; discussion 365-72. PubMed ID: 16462491
[TBL] [Abstract][Full Text] [Related]
5. Bioluminescence imaging to monitor bladder cancer cell adhesion in vivo: a new approach to optimize a syngeneic, orthotopic, murine bladder cancer model.
Jurczok A; Fornara P; Söling A
BJU Int; 2008 Jan; 101(1):120-4. PubMed ID: 17888045
[TBL] [Abstract][Full Text] [Related]
6. An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment.
Huebner D; Rieger C; Bergmann R; Ullrich M; Meister S; Toma M; Wiedemuth R; Temme A; Novotny V; Wirth MP; Bachmann M; Pietzsch J; Fuessel S
BMC Cancer; 2017 Nov; 17(1):790. PubMed ID: 29169339
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of disease progression by bioluminescence imaging and magnetic resonance imaging in an animal model of hematologic malignancy.
Inoue Y; Izawa K; Tojo A; Nomura Y; Sekine R; Oyaizu N; Ohtomo K
Exp Hematol; 2007 Mar; 35(3):407-15. PubMed ID: 17309821
[TBL] [Abstract][Full Text] [Related]
8. In vivo bioluminescence imaging of tumor hypoxia dynamics of breast cancer brain metastasis in a mouse model.
Saha D; Dunn H; Zhou H; Harada H; Hiraoka M; Mason RP; Zhao D
J Vis Exp; 2011 Oct; (56):. PubMed ID: 21989061
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging of human melanoma xenografts in vivo: proton spin-lattice and spin-spin relaxation times versus fractional tumour water content and fraction of necrotic tumour tissue.
Rofstad EK; Steinsland E; Kaalhus O; Chang YB; Høvik B; Lyng H
Int J Radiat Biol; 1994 Mar; 65(3):387-401. PubMed ID: 7908318
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive in vivo imaging of vessel calibre in orthotopic prostate tumour xenografts.
Walker-Samuel S; Boult JK; McPhail LD; Box G; Eccles SA; Robinson SP
Int J Cancer; 2012 Mar; 130(6):1284-93. PubMed ID: 21469141
[TBL] [Abstract][Full Text] [Related]
11. Monitoring the Growth of an Orthotopic Tumour Xenograft Model: Multi-Modal Imaging Assessment with Benchtop MRI (1T), High-Field MRI (9.4T), Ultrasound and Bioluminescence.
Ramasawmy R; Johnson SP; Roberts TA; Stuckey DJ; David AL; Pedley RB; Lythgoe MF; Siow B; Walker-Samuel S
PLoS One; 2016; 11(5):e0156162. PubMed ID: 27223614
[TBL] [Abstract][Full Text] [Related]
12. Multimodality imaging of tumor xenografts and metastases in mice with combined small-animal PET, small-animal CT, and bioluminescence imaging.
Deroose CM; De A; Loening AM; Chow PL; Ray P; Chatziioannou AF; Gambhir SS
J Nucl Med; 2007 Feb; 48(2):295-303. PubMed ID: 17268028
[TBL] [Abstract][Full Text] [Related]
13. Preliminary evaluation of 1'-[(18)F]fluoroethyl-β-D-lactose ([(18)F]FEL) for detection of pancreatic cancer in nude mouse orthotopic xenografts.
Arumugam T; Paolillo V; Young D; Wen X; Logsdon CD; De Palatis L; Alauddin MM
Nucl Med Biol; 2014; 41(10):833-40. PubMed ID: 25189831
[TBL] [Abstract][Full Text] [Related]
14. A multimodality imaging model to track viable breast cancer cells from single arrest to metastasis in the mouse brain.
Parkins KM; Hamilton AM; Makela AV; Chen Y; Foster PJ; Ronald JA
Sci Rep; 2016 Oct; 6():35889. PubMed ID: 27767185
[TBL] [Abstract][Full Text] [Related]
15. Minimally invasive establishment of murine orthotopic bladder xenografts.
Jäger W; Moskalev I; Janssen C; Hayashi T; Gust KM; Awrey S; Black PC
J Vis Exp; 2014 Feb; (84):e51123. PubMed ID: 24561487
[TBL] [Abstract][Full Text] [Related]
16. Establishment of an orthotopic mouse non-muscle invasive bladder cancer model expressing the mammalian target of rapamycin signaling pathway.
Kim SJ; Seo HK; Seo HH; Lee SJ; Kwon JK; Lee TJ; Chi BH; Chang IH
J Korean Med Sci; 2014 Mar; 29(3):343-50. PubMed ID: 24616582
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of imaging techniques for the assessment of tumour progression in an orthotopic rat model of malignant pleural mesothelioma†.
Meerang M; Boss A; Kenkel D; Broggini-Tenzer A; Bérard K; Lauk O; Arni S; Weder W; Opitz I
Eur J Cardiothorac Surg; 2015 Jan; 47(1):e34-41. PubMed ID: 25344922
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging of response to chemotherapy in orthotopic xenografts of human bladder cancer.
Mazurchuk R; Glaves D; Raghavan D
Clin Cancer Res; 1997 Sep; 3(9):1635-41. PubMed ID: 9815854
[TBL] [Abstract][Full Text] [Related]
19. Impact of the tumour bed effect on microenvironment, radiobiological hypoxia and the outcome of fractionated radiotherapy of human FaDu squamous-cell carcinoma growing in the nude mouse.
Zips D; Eicheler W; Brüchner K; Jackisch T; Geyer P; Petersen C; van der Kogel AJ; Baumann M
Int J Radiat Biol; 2001 Dec; 77(12):1185-93. PubMed ID: 11747543
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approach.
Jäger W; Moskalev I; Janssen C; Hayashi T; Awrey S; Gust KM; So AI; Zhang K; Fazli L; Li E; Thüroff JW; Lange D; Black PC
PLoS One; 2013; 8(3):e59536. PubMed ID: 23555699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
